Aadi Bioscience, Inc. (AADI)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.8800 |
| Open | 1.8800 |
| Bid | 1.7500 x 100 |
| Ask | 1.7900 x 200 |
| Day's range | 1.7100 - 1.8900 |
| 52-week range | 1.5500 - 8.6000 |
| Volume | |
| Avg. volume | 342,031 |
| Market cap | 43.706M |
| Beta (5Y monthly) | 0.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.4400 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 11.00 |
Simply Wall St.Analysts Just Made A Major Revision To Their Aadi Bioscience, Inc. (NASDAQ:AADI) Revenue Forecasts
Today is shaping up negative for Aadi Bioscience, Inc. ( NASDAQ:AADI ) shareholders, with the analysts delivering a...
Simply Wall St.Aadi Bioscience First Quarter 2024 Earnings: US$0.68 loss per share (vs US$0.57 loss in 1Q 2023)
Aadi Bioscience ( NASDAQ:AADI ) First Quarter 2024 Results Key Financial Results Revenue: US$5.35m (down 8.8% from 1Q...
PR NewswireAadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update
Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage, precision oncology company focused on developing and commercializing therapies for cancers with alterations in the mTOR pathway, today announced financial results for the first quarter ended March 31, 2024, and highlighted recent corporate progress.
© 2024 Yahoo. All rights reserved.